Clinical Trials Logo

Adolescent Depression clinical trials

View clinical trials related to Adolescent Depression.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT00284791 Terminated - Clinical trials for Adolescent Depression

Lamotrigine in Treatment Resistant Depression in Adolescents

Start date: January 2006
Phase: N/A
Study type: Interventional

The primary hypothesis of this study is that in fluoxetine (Prozac)-resistant adolescents with Major Depressive Disorder (MDD), Lamotrigine plus fluoxetine will be safe and as effective as sertraline (Zoloft). Our Primary Aim is to determine the efficacy and safety of Lamotrigine-augmentation of fluoxetine for treatment-resistant depression in adolescents. Our Secondary Aims are to characterize the factors associated with treatment-resistance for adolescents with major depression. Also to assess the relationships in the families of adolescents with major depression as they enter treatment, and to track the differences in family relationships for adolescents who respond or do not respond. We postulate that tense, frustrated, irritable, and over-involved relationships constitute a risk factor for attenuated improvement or relapse.